Transaction · 0001106578-26-000136

Rothblatt Martine A

ROTHBLATT MARTINE A, CHAIR, CEO, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 320.000000 shares for an estimated $157341.60. Reported holdings after the transaction were 324443.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCHAIR, CEO
UTHRUNITED THERAPEUTICS Corp
Trade date
Sep 04, 2026
Filing date
Sep 08, 2026
View on SEC Insider profile
Estimated value-$157kShares × reported price
Shares traded320$491.69 per share
Holdings after324kIndirect · by Trust
% of reported position traded0.1%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 324,763 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

UTHR price since this filing

Daily closing prices, with the filing date and available return windows
UTHR · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +4.2%1w ago +3.5%1d ago -1.6%
Returns since7d +0.5%30d +7.0%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001106578-26-000136
Common Stock
Transaction date
Sep 04, 2026
Filed Sep 08, 2026, 08:31 PM · 4d delay
Shares
320 sh
$491.69 per share
Estimated value
-$157k
Computed from shares × price
Holdings after
324,443 sh
Indirect · by Trust

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Repeat Seller 10b5-1 Detected
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chairperson & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will c…

  2. F10

    Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

  3. F11

    Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

  4. F12

    Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

  5. F13

    These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.

  6. F14

    Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.

  7. F2

    Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

  8. F3

    This transaction was executed in multiple trades at prices ranging from $485.41 to $486.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  9. F4

    This transaction was executed in multiple trades at prices ranging from $486.43 to $487.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  10. F5

    This transaction was executed in multiple trades at prices ranging from $487.51 to $488.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  11. F6

    This transaction was executed in multiple trades at prices ranging from $488.54 to $489.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  12. F7

    This transaction was executed in multiple trades at prices ranging from $489.57 to $490.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  13. F8

    This transaction was executed in multiple trades at prices ranging from $490.57 to $491.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  14. F9

    This transaction was executed in multiple trades at prices ranging from $491.65 to $491.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

Original filing · 0001106578-26-000136
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

UTHR